Evidence map›Paper›PMID 41602974›Full record

ArticleFrontiers in neurology2025

Levels of 25-hydroxyvitamin D

András Molnár, Panayiota Mavrogeni, Aphrodite Mavrogenis, Stefani Maihoub

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

András MolnárOpera Clinic, Protone Audio Kft., Budapest, Hungary.
Panayiota MavrogeniFaculty of Health Sciences Doctoral School, University of Pécs, Pécs, Hungary.
Aphrodite MavrogenisBajcsy-Zsilinszky Hospital, Budapest, Hungary.
Stefani MaihoubMaihoub ENT Clinic, Limassol, Cyprus.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to analyze vitamin D Materials and methods: A total of 350 patients with primary subjective tinnitus and 347 participants serving as a control group were examined. All patients underwent an otorhinolaryngological examination, audiological testing, and laboratory testing, including measurements of 25-hydroxyvitamin D Results: The prevalence of low 25-hydroxyvitamin D Conclusion: The notably lower levels of 25-hydroxyvitamin D

Indexed as

25-hydroxyvitamin D3 levelschronic subjective tinnitustinnitustinnitus intensitytinnitus severity

Identifiers

PMID41602974
PMCPMC12832500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.